¹¹C-methionine positron-emission tomography and computed tomography (PET-CT) in evaluating metastatic transitional cell carcinoma response to sunitinib therapy

BJU Int. 2010 Nov;106(9):1249-50. doi: 10.1111/j.1464-410x.2010.09732.x.
No abstract available

Publication types

  • Case Reports
  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Angiogenesis Inhibitors / therapeutic use
  • Antineoplastic Agents / therapeutic use*
  • Bone Neoplasms / diagnostic imaging
  • Bone Neoplasms / drug therapy*
  • Bone Neoplasms / radiotherapy
  • Bone Neoplasms / secondary
  • Carbon Radioisotopes*
  • Carcinoma, Transitional Cell / diagnostic imaging
  • Carcinoma, Transitional Cell / drug therapy*
  • Carcinoma, Transitional Cell / secondary
  • Humans
  • Indoles / therapeutic use*
  • Methionine*
  • Positron-Emission Tomography / methods*
  • Pyrroles / therapeutic use*
  • Sunitinib
  • Tomography, X-Ray Computed / methods
  • Treatment Outcome

Substances

  • Angiogenesis Inhibitors
  • Antineoplastic Agents
  • Carbon Radioisotopes
  • Indoles
  • Pyrroles
  • Methionine
  • Sunitinib